TEST-BRAF-TISSUE
TEST-BRAF-TISSUE
The testing kit is used when examining patients diagnosed with the metastatic melanoma stage III-IV in order to determine if they have indications for targeted therapy.
Advantages
- Detects 3 mutations of the BRAF gene.
Reagent kits cannot be used to diagnose any pathology and are intended only for qualitative determination of the BRAF gene mutation status to determine indications for targeted therapy.
Detection method
Real-time PCR
Analysis type
Qualitative
Samples
Formalin-fixed and paraffin-embedded tissue (FFPE blocks)
Analytical sensitivity
10 copies of the BRAF gene per 1 µl of the DNA solution
Sensirtivity
89,1 %
Specificity
94,4 %
Time per 1 analysis
60 minutes
Equipment
CFX96, DTPrime, Rotor-Gene Q, QuantStudio 5, LC96, Abbot m2000rt
Number of isolations
5 / 24
Transportation and
Storage conditions
Storage conditions
+ 2 …+8 °C 12 months
+15 …+25 °C 5 days
Freezing for up to 5 days is allowed during transportation
+15 …+25 °C 5 days
Freezing for up to 5 days is allowed during transportation
Designed by